Turbine and Daiichi Sankyo, a global healthcare company with an industry-leading antibody-drug conjugate (ADC) portfolio, today announced a strategic partnership to accelerate and de-risk ADC… read more
Turbine and Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership to advance translational oncology… read more
Budapest-based Turbine has closed a $25 million Series B round, funding the next iteration of the decade-old startup’s long-running quest to build virtual cells. read more
Turbine, a leading virtual biology company, today announced a $25 million Series B financing, an expansion of its virtual cell platform across industries and a… read more
AI promises to create medicines faster, more cheaply, and with greater precision. Despite attracting big sums and splashy headlines, AI-powered biotechs have yet to get… read more
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the trade name of Merck & Co., Inc., Rahway… read more